- Home
- AVIR vs ALLT Comparison
AVIR vs ALLT Comparison
Compare AVIR & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ALLT
- Stock Information
- Founded
- AVIR 2012
- ALLT 1996
- Country
- AVIR United States
- ALLT Israel
- Employees
- AVIR N/A
- ALLT N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ALLT Telecommunications Equipment
- Sector
- AVIR Health Care
- ALLT Telecommunications
- Exchange
- AVIR Nasdaq
- ALLT Nasdaq
- Market Cap
- AVIR 273.7M
- ALLT 229.8M
- IPO Year
- AVIR 2020
- ALLT 2006
- Fundamental
- Price
- AVIR $2.85
- ALLT $5.53
- Analyst Decision
- AVIR Hold
- ALLT Buy
- Analyst Count
- AVIR 1
- ALLT 1
- Target Price
- AVIR $6.88
- ALLT $13.00
- AVG Volume (30 Days)
- AVIR 247.5K
- ALLT 565.5K
- Earning Date
- AVIR 03-06-2025
- ALLT 05-28-2025
- Dividend Yield
- AVIR N/A
- ALLT N/A
- EPS Growth
- AVIR N/A
- ALLT N/A
- EPS
- AVIR N/A
- ALLT N/A
- Revenue
- AVIR N/A
- ALLT $92,195,000.00
- Revenue This Year
- AVIR N/A
- ALLT $6.43
- Revenue Next Year
- AVIR N/A
- ALLT $5.83
- P/E Ratio
- AVIR N/A
- ALLT N/A
- Revenue Growth
- AVIR N/A
- ALLT N/A
- 52 Week Low
- AVIR $2.75
- ALLT $1.99
- 52 Week High
- AVIR $4.15
- ALLT $9.44
- Technical
- Relative Strength Index (RSI)
- AVIR 36.06
- ALLT 40.14
- Support Level
- AVIR $2.90
- ALLT $5.45
- Resistance Level
- AVIR $3.29
- ALLT $7.00
- Average True Range (ATR)
- AVIR 0.12
- ALLT 0.42
- MACD
- AVIR -0.03
- ALLT 0.03
- Stochastic Oscillator
- AVIR 8.33
- ALLT 14.04
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.